BioStock

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Three shots on goal: Saniona prepares to enter the clinic

2026-06-11 09:10:00

Backed by more than SEK 530 million in cash, Saniona is entering the most operationally intensive phase in its history with three wholly owned ion channel programs heading into the clinic. The May AGM struck a more cautious note, as the board withdrew two key proposals in the face of shareholder opposition and pledged to come back with reworked versions. We turned to CEO Thomas Feldthus for a comment.

Read the full interview at biostock.se:

Three shots on goal: Saniona prepares to enter the clinic

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook! 

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BioStock

Prenumeration

Vem äger bolaget?

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden